Trial Profile
Comparative study investigating early clinical outcomes of ABSORB bioresorbable vascular scaffold (BVS) compared to Everolimus-eluting stents in a real world population
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 11 Dec 2015 New trial record